Heart Valve Devices Market Report and Forecast 2025-2034
Description
The global heart valve devices market size was valued at USD 10.30 Billion in 2024, driven by the increasing incidence of cardiovascular diseases across the globe. The market size is anticipated to grow at a CAGR of 12.90% during the forecast period of 2025-2034 to achieve a value of USD 34.66 Billion by 2034.
Heart Valve Devices: Introduction
A heart valve is a one-way valve that allows blood to pass through the heart only in one direction. In a mammalian heart, the four valves are frequently represented to show the blood flow pattern through the heart. Depending on the blood pressure differences on each side, a heart valve may open or close as needed. The valves occasionally fail to open or seal precisely. This happens when the blood flow from the heart to the rest of the body is obstructed. It is also known as heart valve disease, and the course of treatment for this condition varies on the heart valve in question as well as the type and degree of the disease.
Global Heart Valve Devices Market Analysis
The global market for heart valve devices is experiencing a surge in growth driven by several key trends. The key trends in the market include increased investments by the key players in the market. For example, Xeltis' successful fundraising is propelling the development of advanced restorative cardiovascular devices. Xeltis, a pioneering medical technology company, is a leader in heart valve replacement and vascular therapies, with the aim of providing patients worldwide access to cutting-edge treatments.
Furthermore, increased research and development activities focused on finding optimal treatments for cardiovascular diseases are significantly proeplling the global heart valve replacement market growth as well. The newly launched products by the key players in the market are also enhancing the market value. For example, minimally invasive procedures like the EVOQUE tricuspid valve replacement system shorten patient recovery times and improve outcomes. This investigational device offers a less invasive alternative to open-heart surgery, showcasing the relentless pursuit of innovative solutions in cardiovascular care.
Additionally, the increased number of clinical trials conducted by key players is further fueling the market growth. For example, Abbott highlights the commitment to advancing treatment options. Abbott's successful clinical trial involving tricuspid valve clipping demonstrates the continuous efforts to enhance patient outcomes and reduce risks.
In conclusion, these market trends collectively contribute to the robust global heart valve devices market growth.
Global Heart Valve Devices Market Segmentations
Heart Valve Devices Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Product Type
The market is experiencing robust growth driven by the rising number of various heart diseases worldwide, with coronary heart disease being a significant contributor to cardiovascular-related mortality. This prevalence emphasizes the growing demand for advanced heart valve devices to address these conditions. Additionally, there is a substantial shift in preference toward minimally invasive treatment strategies, particularly for complex heart disorders like mitral regurgitation. This shift aligns with the increasing advancements in technology, leading to the development of exceptional products in the market. Continuous innovation in valve technologies by medical device manufacturers is creating new opportunities for the market, further propelling the global heart valve devices market growth.
Geographically, North America is currently leading the regional market and is expected to lead the market in the coming years as well. The region has the presence of a robust healthcare system and key market players. The market is further driven by increased awareness among people regarding the benefits of minimally invasive procedures and robot-assisted surgeries. These drivers collectively contribute to the thriving global heart valve devices market.
Global Heart Valve Devices Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Heart Valve Devices: Introduction
A heart valve is a one-way valve that allows blood to pass through the heart only in one direction. In a mammalian heart, the four valves are frequently represented to show the blood flow pattern through the heart. Depending on the blood pressure differences on each side, a heart valve may open or close as needed. The valves occasionally fail to open or seal precisely. This happens when the blood flow from the heart to the rest of the body is obstructed. It is also known as heart valve disease, and the course of treatment for this condition varies on the heart valve in question as well as the type and degree of the disease.
Global Heart Valve Devices Market Analysis
The global market for heart valve devices is experiencing a surge in growth driven by several key trends. The key trends in the market include increased investments by the key players in the market. For example, Xeltis' successful fundraising is propelling the development of advanced restorative cardiovascular devices. Xeltis, a pioneering medical technology company, is a leader in heart valve replacement and vascular therapies, with the aim of providing patients worldwide access to cutting-edge treatments.
Furthermore, increased research and development activities focused on finding optimal treatments for cardiovascular diseases are significantly proeplling the global heart valve replacement market growth as well. The newly launched products by the key players in the market are also enhancing the market value. For example, minimally invasive procedures like the EVOQUE tricuspid valve replacement system shorten patient recovery times and improve outcomes. This investigational device offers a less invasive alternative to open-heart surgery, showcasing the relentless pursuit of innovative solutions in cardiovascular care.
Additionally, the increased number of clinical trials conducted by key players is further fueling the market growth. For example, Abbott highlights the commitment to advancing treatment options. Abbott's successful clinical trial involving tricuspid valve clipping demonstrates the continuous efforts to enhance patient outcomes and reduce risks.
In conclusion, these market trends collectively contribute to the robust global heart valve devices market growth.
Global Heart Valve Devices Market Segmentations
Heart Valve Devices Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Product Type
- Mechanical Heart Valves
- Biological Heart Valves
- Transcatheter Valves
- Open Surgery
- Minimally Invasive Surgery (MIS)
- Hospitals
- Speciality Clinics
- Home Healthcare
- Others
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
The market is experiencing robust growth driven by the rising number of various heart diseases worldwide, with coronary heart disease being a significant contributor to cardiovascular-related mortality. This prevalence emphasizes the growing demand for advanced heart valve devices to address these conditions. Additionally, there is a substantial shift in preference toward minimally invasive treatment strategies, particularly for complex heart disorders like mitral regurgitation. This shift aligns with the increasing advancements in technology, leading to the development of exceptional products in the market. Continuous innovation in valve technologies by medical device manufacturers is creating new opportunities for the market, further propelling the global heart valve devices market growth.
Geographically, North America is currently leading the regional market and is expected to lead the market in the coming years as well. The region has the presence of a robust healthcare system and key market players. The market is further driven by increased awareness among people regarding the benefits of minimally invasive procedures and robot-assisted surgeries. These drivers collectively contribute to the thriving global heart valve devices market.
Global Heart Valve Devices Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- AgaMatrix Holdings LLC
- Coloplast Corp
- 3M Co.
- Cardinal Health
- ConvaTec Inc.
- B. Braun Melsungen AG
- SMITH & NEPHEW
- Convatec Group PLC
- Medline Industries
- Integra Lifesciences Corp.
- Mckesson Corporation
- Dermarite Industries, LLC
- Amerx Health Care Corp
Table of Contents
350 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Heart Valve Devices Market Overview
- 3.1 Global Heart Valve Devices Market Historical Value (2018-2024)
- 3.2 Global Heart Valve Devices Market Forecast Value (2025-2034)
- 4 Global Heart Valve Devices Market Landscape
- 4.1 Global Heart Valve Devices Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Global Heart Valve Devices Product Landscape
- 4.2.1 Analysis by Type of Biosensor
- 4.2.2 Analysis by Technology Used
- 4.2.3 Analysis by Applications
- 5 Global Heart Valve Devices Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.3 Porter’s Five Forces Model
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global Heart Valve Devices Market Segmentation
- 6.1 Global Heart Valve Devices Market by Product Type
- 6.1.1 Market Overview
- 6.1.2 Mechanical Heart Valves
- 6.1.3 Biological Heart Valves
- 6.1.4 Transcatheter Valves
- 6.2 Global Heart Valve Devices Market by Treatment
- 6.2.1 Market Overview
- 6.2.2 Open Surgery
- 6.2.3 Minimally Invasive Surgery (MIS)
- 6.3 Global Heart Valve Devices Market by End User
- 6.3.1 Market Overview
- 6.3.2 Hospitals
- 6.3.3 Speciality Clinics
- 6.3.4 Home Healthcare
- 6.3.5 Others
- 6.4 Global Heart Valve Devices Market by Region
- 6.4.1 Market Overview
- 6.4.2 North America
- 6.4.3 Europe
- 6.4.4 Asia Pacific
- 6.4.5 Latin America
- 6.4.6 Middle East and Africa
- 7 North America Heart Valve Devices Market
- 7.1 Market Share by Country
- 7.2 United States of America
- 7.3 Canada
- 8 Europe Heart Valve Devices Market
- 8.1 Market Share by Country
- 8.2 United Kingdom
- 8.3 Germany
- 8.4 France
- 8.5 Italy
- 8.6 Others
- 9 Asia Pacific Heart Valve Devices Market
- 9.1 Market Share by Country
- 9.2 China
- 9.3 Japan
- 9.4 India
- 9.5 ASEAN
- 9.6 Australia
- 9.7 Others
- 10 Latin America Heart Valve Devices Market
- 10.1 Market Share by Country
- 10.2 Brazil
- 10.3 Argentina
- 10.4 Mexico
- 10.5 Others
- 11 Middle East and Africa Heart Valve Devices Market
- 11.1 Market Share by Country
- 11.2 Saudi Arabia
- 11.3 United Arab Emirates
- 11.4 Nigeria
- 11.5 South Africa
- 11.6 Others
- 12 Patent Analysis
- 12.1 Analysis by Type of Patent
- 12.2 Analysis by Publication year
- 12.3 Analysis by Issuing Authority
- 12.4 Analysis by Patent Age
- 12.5 Analysis by CPC Analysis
- 12.6 Analysis by Patent Valuation
- 12.7 Analysis by Key Players
- 13 Grants Analysis
- 13.1 Analysis by year
- 13.2 Analysis by Amount Awarded
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Grant Application
- 13.5 Analysis by Funding Institute
- 13.6 Analysis by NIH Departments
- 13.7 Analysis by Recipient Organization
- 14 Funding Analysis
- 14.1 Analysis by Funding Instances
- 14.2 Analysis by Type of Funding
- 14.3 Analysis by Funding Amount
- 14.4 Analysis by Leading Players
- 14.5 Analysis by Leading Investors
- 14.6 Analysis by Geography
- 15 Partnership and Collaborations Analysis
- 15.1 Analysis by Partnership Instances
- 15.2 Analysis by Type of Partnership
- 15.3 Analysis by Leading Players
- 15.4 Analysis by Geography
- 16 Regulatory Framework
- 16.1 Regulatory Overview
- 16.1.1 US FDA
- 16.1.2 EU EMA
- 16.1.3 INDIA CDSCO
- 16.1.4 JAPAN PMDA
- 16.1.5 Others
- 17 Supplier Landscape
- 17.1 AgaMatrix Holdings LLC
- 17.1.1 Financial Analysis
- 17.1.2 Product Portfolio
- 17.1.3 Demographic Reach and Achievements
- 17.1.4 Mergers and Acquisitions
- 17.1.5 Certifications
- 17.2 Coloplast Corp
- 17.2.1 Financial Analysis
- 17.2.2 Product Portfolio
- 17.2.3 Demographic Reach and Achievements
- 17.2.4 Mergers and Acquisitions
- 17.2.5 Certifications
- 17.3 3M Co.
- 17.3.1 Financial Analysis
- 17.3.2 Product Portfolio
- 17.3.3 Demographic Reach and Achievements
- 17.3.4 Mergers and Acquisitions
- 17.3.5 Certifications
- 17.4 Cardinal Health
- 17.4.1 Financial Analysis
- 17.4.2 Financial Portfolio
- 17.4.3 Demographic Reach and Achievements
- 17.4.4 Mergers and Acquisitions
- 17.4.5 Certifications
- 17.5 ConvaTec Inc.
- 17.5.1 Financial Analysis
- 17.5.2 Product Portfolio
- 17.5.3 Demographic Reach and Achievements
- 17.5.4 Mergers and Acquisitions
- 17.5.5 Certifications
- 17.6 B. Braun Melsungen AG
- 17.6.1 Financial Analysis
- 17.6.2 Product Portfolio
- 17.6.3 Demographic Reach and Achievements
- 17.6.4 Mergers and Acquisitions
- 17.6.5 Certifications
- 17.7 SMITH & NEPHEW
- 17.7.1 Financial Analysis
- 17.7.2 Product Portfolio
- 17.7.3 Demographic Reach and Achievements
- 17.7.4 Mergers and Acquisitions
- 17.7.5 Certifications
- 17.8 Convatec Group PLC
- 17.8.1 Financial Analysis
- 17.8.2 Product Portfolio
- 17.8.3 Demographic Reach and Achievements
- 17.8.4 Mergers and Acquisitions
- 17.8.5 Certifications
- 17.9 Medline Industries
- 17.9.1 Financial Analysis
- 17.9.2 Product Portfolio
- 17.9.3 Demographic Reach and Achievements
- 17.9.4 Mergers and Acquisitions
- 17.9.5 Certifications
- 17.10 Integra Lifesciences Corp.
- 17.10.1 Financial Analysis
- 17.10.2 Product Portfolio
- 17.10.3 Demographic Reach and Achievements
- 17.10.4 Mergers and Acquisitions
- 17.10.5 Certifications
- 17.11 Mckesson Corporation
- 17.11.1 Financial Analysis
- 17.11.2 Product Portfolio
- 17.11.3 Demographic Reach and Achievements
- 17.11.4 Mergers and Acquisitions
- 17.11.5 Certifications
- 17.12 Dermarite Industries, LLC
- 17.12.1 Financial Analysis
- 17.12.2 Product Portfolio
- 17.12.3 Demographic Reach and Achievements
- 17.12.4 Mergers and Acquisitions
- 17.12.5 Certifications
- 17.13 Amerx Health Care Corp.
- 17.13.1 Financial Analysis
- 17.13.2 Product Portfolio
- 17.13.3 Demographic Reach and Achievements
- 17.13.4 Mergers and Acquisitions
- 17.13.5 Certifications
- 18 Global Heart Valve Devices Market - Distribution Model (Additional Insight)
- 18.1 Overview
- 18.2 Potential Distributors
- 18.3 Key Parameters for Distribution Partner Assessment
- 19 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 20 Company Competitiveness Analysis (Additional Insight)
- 20.1 Very Small Companies
- 20.2 Small Companies
- 20.3 Mid-Sized Companies
- 20.4 Large Companies
- 20.5 Very Large Companies
- 21 Payment Methods (Additional Insight)
- 21.1 Government Funded
- 21.2 Private Insurance
- 21.3 Out-of-Pocket
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
